Product Code: VMR11211450
The global demand for Polymerase Chain Reaction Market is presumed to reach the market size of nearly USD 15.82 Billion by 2032 from USD 35.2 Billion in 2023 with a CAGR of -8.5% under the study period 2024 - 2032.
Polymerase chain reaction amplifies the small segments of RNA and DNA strands into billions of copies and this technique is majorly exploited in genetic engineering, molecular biology, archeology, drug discovery, and clinical diagnostics. The technology is also utilized in forensics to identify criminals and also in child identity. Moreover, PCR is also used in diagnosis of diseases including AIDS, tuberculosis, Lyme diseases, and middle ear infections. Specific technology segments of PCR such as qPCR (real-time PCR) and dPCR (digital PCR) provides real-time process monitoring, automation of workflow, low reagent consumption, and greater reproducibility & precision. Furthermore, polymerase chain reaction is an easy and cost-efficient procedure to replicate the focuses DNA segment.
Market Dynamics
Personalized medicine which focuses to offer tailor-made therapies to individual patients is gaining immense traction over the last few years. Personalized medicine provides better patient care coupled with high safety margin and also lowers the overall healthcare costs. Increasing demand for personalized medicine created immense opportunities in the field of genetic medicine. To gain a competitive edge in the development of personalized medicine pharmaceutical and biotechnology firms are exploiting genomic medicine and direct to consumer genetic testing. In order to develop these products various R&D activities are being conducted in the field of biotechnology where PCR find its immense applications.
Moreover, PCR is also utilized in molecular diagnosis of genetic and infectious diseases. Genetic tests are crucial in detecting the genetic variations and to predict the response of an individual to certain drugs. To promote personalized medicine, PCR technologies are widely used to attain accurate and precise molecular information about the underlying disease. Hence, increasing attention on personalized medicine and patient centered approach is propelling the growth of the market. However, the advent of alternative technologies such as next generation sequencing coupled with high cost of commercial PCR technologies hampers the market growth. Increase in the funding for R&D activities and the presence of untapped market in emerging economies are anticipated to provide lucrative opportunities for the market in the forecast period.
The report has been created by using crucial tools such as Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis to help businesses around the globe navigate opportunities and challenges in the rapidly evolving marketplace with clarity. These tools also serve the detailed information of each application/product segment in the global market of polymerase chain reaction.
Market Segmentation
The study offers a decisive view of the global polymerase chain reaction market by segmenting it terms of product, application, and end-user. The report analyzes these subsets with respect to the regional segmentation. This research study will prepare marketers for the evolving needs of their customers.
By Type
By Product
- Consumables & Reagents
- Instruments
- Software & Services
By Application
- Medical (Clinical (Pathology Testing, Oncology Testing, Blood Screening,Others), Research, Forensics and Others)
- Non-medical (Food, Others)
- Regional Analysis
This section covers polymerase chain reaction market for the regions North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional segmentation has been done based on the present and future trends in the global polymerase chain reaction market along with the individual application segment across all the prominent region.
- This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global Polymerase Chain Reaction market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Cepheid, Agilent Technologies, bioMerieux SA, GE Healthcare, Stilla, Microsynth AG, JN Medsys, and Fluidigm Corporation. This section cover profiling of major players in terms of important aspects such as company overview, financial overview, business strategy, and recent developments undertaken during the forecast horizon.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. POLYMERASE CHAIN REACTION - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL POLYMERASE CHAIN REACTION MARKET ANALYSIS BY TYPE
- 5.1. Overview By Type
- 5.2. Historical and Forecast Data
- 5.3. Analysis By Type
- 5.4. Conventional PCR Historic and Forecast Sales By Regions
- 5.5. Others Historic and Forecast Sales By Regions
6. GLOBAL POLYMERASE CHAIN REACTION MARKET ANALYSIS BY PRODUCT
- 6.1. Overview By Product
- 6.2. Historical and Forecast Data
- 6.3. Analysis By Product
- 6.4. Consumables & Reagents Historic and Forecast Sales By Regions
- 6.5. Instruments Historic and Forecast Sales By Regions
- 6.6. Software & Services Historic and Forecast Sales By Regions
7. GLOBAL POLYMERASE CHAIN REACTION MARKET ANALYSIS BY APPLICATION
- 7.1. Overview By Application
- 7.2. Historical and Forecast Data
- 7.3. Analysis By Application
- 7.4. Medical (Clinical (Pathology Testing, Oncology Testing, Blood Screening,Others), Research, Forensics and Others) Historic and Forecast Sales By Regions
- 7.5. Non-medical (Food, Others) Historic and Forecast Sales By Regions
8. GLOBAL POLYMERASE CHAIN REACTION MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE POLYMERASE CHAIN REACTION COMPANIES
- 9.1. Polymerase Chain Reaction Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF POLYMERASE CHAIN REACTION INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Bio-Rad Laboratories Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. QIAGEN
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. F. Hoffmann-La Roche Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Abbott Laboratories
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Cepheid
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Agilent Technologies
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. BioMeRieux SA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. GE Healthcare
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. Stilla
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
- 10.13. Microsynth AG
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
- 10.14. JN Medsys
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
- 10.15. Fluidigm Corporation.
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies